Biologics Regulatory Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures byTim AllenNovember 12, 2024
Financial Sports Medicine The Global Bone Void Fillers Market size is expected to reach $6.1 billion by 2030, rising at a market growth of 7.9% CAGR during the forecast period byJosh SandbergJuly 31, 2023
Biologics Regulatory Abyrx Receives Additional FDA Clearances for MONTAGE® Settable, Resorbable Bone Putty as Bone Void Filler and Cranial Bone Cement byJosh SandbergApril 5, 2023
Biologics Regulatory Spine NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty byJosh SandbergFebruary 21, 2023
Biologics Top Stories curasan AG broadens orthobiologic portfolio with the launch of CERASORB® CPC (Calcium Phosphate Cement) bone void fillers. byJosh SandbergJuly 25, 2022
Biologics Regulatory Top Stories Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications byJosh SandbergJuly 13, 2022
Financial Global Bone Void Fillers Market estimated at $3.5 billion (2022), is growing at a CAGR of 6% byJosh SandbergMay 16, 2022
Spine Top Stories Bone Solutions Inc. Receives FDA Clearance for Mg OSTEOREVIVE Spine Magnesium-Based Bone Void Filler byJosh SandbergFebruary 2, 2022
Biologics Spine Top Stories Bone Solutions Launches Mg OSTEOINJECT Injectable Magnesium-Based Bone Void Filler byJosh SandbergJanuary 25, 2022
Hospitals Recon Top Stories HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler byJosh SandbergNovember 30, 2021
